CAMTEK LTD (CAMT) Fundamental Analysis & Valuation

NASDAQ:CAMT • IL0010952641

161.58 USD
+5.3 (+3.39%)
Last: Mar 11, 2026, 03:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CAMT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall CAMT gets a fundamental rating of 5 out of 10. We evaluated CAMT against 115 industry peers in the Semiconductors & Semiconductor Equipment industry. CAMT has only an average score on both its financial health and profitability. CAMT is valued quite expensive, but it does show an excellent growth. This makes CAMT very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. CAMT Profitability Analysis

1.1 Basic Checks

  • In the past year CAMT was profitable.
  • CAMT had positive earnings in each of the past 5 years.
  • Of the past 5 years CAMT 4 years had a positive operating cash flow.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.03%, CAMT is in the better half of the industry, outperforming 61.74% of the companies in the same industry.
  • CAMT's Return On Equity of 8.22% is fine compared to the rest of the industry. CAMT outperforms 68.70% of its industry peers.
  • With a decent Return On Invested Capital value of 8.82%, CAMT is doing good in the industry, outperforming 78.26% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CAMT is in line with the industry average of 10.52%.
Industry RankSector Rank
ROA 4.03%
ROE 8.22%
ROIC 8.82%
ROA(3y)9.1%
ROA(5y)9.89%
ROE(3y)15.44%
ROE(5y)17.53%
ROIC(3y)9.34%
ROIC(5y)10.06%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of CAMT (10.22%) is better than 66.09% of its industry peers.
  • In the last couple of years the Profit Margin of CAMT has declined.
  • CAMT's Operating Margin of 25.94% is amongst the best of the industry. CAMT outperforms 83.48% of its industry peers.
  • CAMT's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CAMT (50.56%) is better than 63.48% of its industry peers.
  • CAMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.94%
PM (TTM) 10.22%
GM 50.56%
OM growth 3Y0.71%
OM growth 5Y12.32%
PM growth 3Y-25.69%
PM growth 5Y-6.06%
GM growth 3Y0.5%
GM growth 5Y1.48%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CAMT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CAMT is destroying value.
  • CAMT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CAMT has more shares outstanding
  • Compared to 1 year ago, CAMT has a worse debt to assets ratio.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • CAMT has an Altman-Z score of 8.60. This indicates that CAMT is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CAMT (8.60) is better than 66.09% of its industry peers.
  • A Debt/Equity ratio of 0.84 indicates that CAMT is somewhat dependend on debt financing.
  • CAMT has a Debt to Equity ratio of 0.84. This is amonst the worse of the industry: CAMT underperforms 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 8.6
ROIC/WACC0.73
WACC12.15%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 8.35 indicates that CAMT has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 8.35, CAMT belongs to the best of the industry, outperforming 87.83% of the companies in the same industry.
  • CAMT has a Quick Ratio of 7.31. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
  • CAMT has a better Quick ratio (7.31) than 87.83% of its industry peers.
Industry RankSector Rank
Current Ratio 8.35
Quick Ratio 7.31
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. CAMT Growth Analysis

3.1 Past

  • CAMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.23%, which is quite good.
  • Measured over the past years, CAMT shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.06% on average per year.
  • CAMT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.65%.
  • Measured over the past years, CAMT shows a very strong growth in Revenue. The Revenue has been growing by 26.06% on average per year.
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
Revenue 1Y (TTM)15.65%
Revenue growth 3Y15.63%
Revenue growth 5Y26.06%
Sales Q2Q%9.23%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.41% on average over the next years. This is quite good.
  • CAMT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.80% yearly.
EPS Next Y8.89%
EPS Next 2Y16.72%
EPS Next 3Y16.49%
EPS Next 5Y19.41%
Revenue Next Year12.01%
Revenue Next 2Y15.26%
Revenue Next 3Y15.17%
Revenue Next 5Y16.8%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. CAMT Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 50.34, CAMT can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, CAMT is valued a bit cheaper than the industry average as 63.48% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.25, CAMT is valued quite expensively.
  • With a Price/Forward Earnings ratio of 46.23, CAMT can be considered very expensive at the moment.
  • CAMT's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 24.39. CAMT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 50.34
Fwd PE 46.23
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CAMT does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of CAMT may justify a higher PE ratio.
  • CAMT's earnings are expected to grow with 16.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.66
PEG (5Y)1.32
EPS Next 2Y16.72%
EPS Next 3Y16.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CAMT Dividend Analysis

5.1 Amount

  • No dividends for CAMT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAMT Fundamentals: All Metrics, Ratios and Statistics

CAMTEK LTD

NASDAQ:CAMT (3/11/2026, 3:59:00 PM)

161.58

+5.3 (+3.39%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-18
Earnings (Next)05-11
Inst Owners55.34%
Inst Owner Change-2.8%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap7.41B
Revenue(TTM)496.07M
Net Income(TTM)50.72M
Analysts81.11
Price Target177.31 (9.74%)
Short Float %11.05%
Short Ratio5.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.33
Dividend Growth(5Y)56.74%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.12%
Min EPS beat(2)-2.36%
Max EPS beat(2)0.11%
EPS beat(4)2
Avg EPS beat(4)-1%
Min EPS beat(4)-2.36%
Max EPS beat(4)0.51%
EPS beat(8)6
Avg EPS beat(8)1.58%
EPS beat(12)9
Avg EPS beat(12)2.04%
EPS beat(16)12
Avg EPS beat(16)1.63%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-0.59%
Revenue beat(8)2
Avg Revenue beat(8)-0.4%
Revenue beat(12)2
Avg Revenue beat(12)-0.58%
Revenue beat(16)2
Avg Revenue beat(16)-0.83%
PT rev (1m)26.5%
PT rev (3m)39.98%
EPS NQ rev (1m)-1.73%
EPS NQ rev (3m)-0.96%
EPS NY rev (1m)2.95%
EPS NY rev (3m)4.17%
Revenue NQ rev (1m)3.41%
Revenue NQ rev (3m)4.02%
Revenue NY rev (1m)5.56%
Revenue NY rev (3m)6.13%
Valuation
Industry RankSector Rank
PE 50.34
Fwd PE 46.23
P/S 14.93
P/FCF N/A
P/OCF N/A
P/B 12
P/tB 13.9
EV/EBITDA N/A
EPS(TTM)3.21
EY1.99%
EPS(NY)3.5
Fwd EY2.16%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.82
BVpS13.46
TBVpS11.62
PEG (NY)5.66
PEG (5Y)1.32
Graham Number31.18
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 8.22%
ROCE 11.17%
ROIC 8.82%
ROICexc 21%
ROICexgc 25.43%
OM 25.94%
PM (TTM) 10.22%
GM 50.56%
FCFM N/A
ROA(3y)9.1%
ROA(5y)9.89%
ROE(3y)15.44%
ROE(5y)17.53%
ROIC(3y)9.34%
ROIC(5y)10.06%
ROICexc(3y)18.07%
ROICexc(5y)29.31%
ROICexgc(3y)22.71%
ROICexgc(5y)32.19%
ROCE(3y)11.82%
ROCE(5y)12.73%
ROICexgc growth 3Y-9.39%
ROICexgc growth 5Y-5.81%
ROICexc growth 3Y-14.91%
ROICexc growth 5Y-9.14%
OM growth 3Y0.71%
OM growth 5Y12.32%
PM growth 3Y-25.69%
PM growth 5Y-6.06%
GM growth 3Y0.5%
GM growth 5Y1.48%
F-ScoreN/A
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.35
Quick Ratio 7.31
Altman-Z 8.6
F-ScoreN/A
WACC12.15%
ROIC/WACC0.73
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
EPS Next Y8.89%
EPS Next 2Y16.72%
EPS Next 3Y16.49%
EPS Next 5Y19.41%
Revenue 1Y (TTM)15.65%
Revenue growth 3Y15.63%
Revenue growth 5Y26.06%
Sales Q2Q%9.23%
Revenue Next Year12.01%
Revenue Next 2Y15.26%
Revenue Next 3Y15.17%
Revenue Next 5Y16.8%
EBIT growth 1Y17.96%
EBIT growth 3Y16.45%
EBIT growth 5Y41.58%
EBIT Next Year10.23%
EBIT Next 3Y14.63%
EBIT Next 5Y16.51%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CAMTEK LTD / CAMT FAQ

What is the fundamental rating for CAMT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CAMT.


What is the valuation status of CAMTEK LTD (CAMT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CAMTEK LTD (CAMT). This can be considered as Overvalued.


How profitable is CAMTEK LTD (CAMT) stock?

CAMTEK LTD (CAMT) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CAMT stock?

The Price/Earnings (PE) ratio for CAMTEK LTD (CAMT) is 50.34 and the Price/Book (PB) ratio is 12.


What is the financial health of CAMTEK LTD (CAMT) stock?

The financial health rating of CAMTEK LTD (CAMT) is 5 / 10.